Neuspera Medical Raises $23 Million in Series D Financing led by Vertex Ventures HC and Treo Ventures
Neuspera Medical Raises $23 Million in Series D Financing led by Vertex Ventures HC and Treo Ventures
07/15/24, 1:13 PM
Location
san joseMoney raised
$23 million
Industry
healthcare
Round Type
series d
Investors
Olympus Innovation Ventures, Windham Venture Partners, Action Potential Venture Capital, Treo Ventures, Vertex Ventures Hc
Neuspera Medical, Inc., a neuromodulation company, has closed its Series D funding round, raising $23 million. The round was led by Vertex Ventures HC and Treo Ventures, with participation from Action Potential Venture Capital, Windham Venture Partners, Olympus Innovation Ventures, and another strategic investor. The funding will support the expected U.S. Food and Drug Administration (FDA) premarket approval (PMA) of the Neuspera System, designed to provide relief from urinary urge incontinence (UUI), a symptom of overactive bladder (OAB).
Company Info
Location
51 daggett drive
san jose, california, united states
Additional Info
Neuspera Medical, Inc. is committed to developing implantable medical devices that will improve the lives of patients battling chronic illnesses. The Neuspera platform is designed to provide patients and physicians with new, and potentially earlier, treatment options that are less invasive and more adaptable. These therapeutic alternatives aim to help patients restore their health and well-being for a better quality of life.